Loading...
dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 1204352005

Production
add
1204352005
The component that hold information about this concept.
Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Pyrazinamide 150 mg dispersible oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug)

SCTID: 1204352005, Defined, Active


1204352005|Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug)|
  • en Pyrazinamide 150 mg dispersible oral tablet
  • en Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug)
  • en Pyrazinamide 150 mg tablet for oral suspension

1204352005 |Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug)|

=== 421366001 |Tablet for conventional release oral suspension (dose form)| +
    732936001 |Tablet (unit of presentation)| +
    780327000 |Product containing only pyrazinamide in oral dose form (medicinal product form)| :
        { 732943007 |Has basis of strength substance (attribute)| = 387076005 |Pyrazinamide (substance)|,
          762949000 |Has precise active ingredient (attribute)| = 387076005 |Pyrazinamide (substance)|,
          732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
          732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
Active

5259837018 - Pyrazinamide 150 mg dispersible oral tablet (en) View

5259837018
en
Synonym (core metadata concept)
Pyrazinamide 150 mg dispersible oral tablet
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

4953832015 - Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug) (en) View

4953832015
en
Fully specified name (core metadata concept)
Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug)
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

4953833013 - Pyrazinamide 150 mg tablet for oral suspension (en) View

4953833013
en
Synonym (core metadata concept)
Pyrazinamide 150 mg tablet for oral suspension
900000000000448009 |Entire term case insensitive (core metadata concept)|
Acceptable
True

Relationship (15072318023) - 1204352005 -> 789696002 (766939001) View

766939001 |Plays role (attribute)|
789696002 |Antitubercular therapeutic role (role)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (15072314020) - 1204352005 -> 780327000 (116680003) View

116680003 |Is a (attribute)|
780327000 |Product containing only pyrazinamide in oral dose form (medicinal product form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15072315021) - 1204352005 -> 421366001 (411116001) View

411116001 |Has dose form (attribute)|
421366001 |Tablet for conventional release oral suspension (dose form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15072316022) - 1204352005 -> 732936001 (763032000) View

763032000 |Has unit of presentation (attribute)|
732936001 |Tablet (unit of presentation)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15072319026) - 1204352005 -> 387076005 (762949000) View

762949000 |Has precise active ingredient (attribute)|
387076005 |Pyrazinamide (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15072320021) - 1204352005 -> 387076005 (732943007) View

732943007 |Has basis of strength substance (attribute)|
387076005 |Pyrazinamide (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15072322029) - 1204352005 -> 258684004 (732945000) View

732945000 |Has presentation strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15072324028) - 1204352005 -> 732936001 (732947008) View

732947008 |Has presentation strength denominator unit (attribute)|
732936001 |Tablet (unit of presentation)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

780327000 View

780327000
Product containing only pyrazinamide in oral dose form (medicinal product form)
Pyrazinamide only product in oral dose form
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

421366001 View

421366001
Tablet for conventional release oral suspension (dose form)
Dispersible oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

732936001 View

732936001
Tablet (unit of presentation)
Tablet
900000000000074008 |Necessary but not sufficient concept definition status (core metadata concept)|
True
esc